1	[	[	O	(	O	15	DEP
2	Value	Value	B-NP	NN	O	15	DEP
3	of	of	B-PP	IN	O	2	NMOD
4	protein	protein	B-NP	NN	O	5	NMOD
5	array	array	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	diagnosis	diagnosis	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	Helicobactor	Helicobactor	B-NP	NN	O	12	NMOD
11	pylori	pylori	I-NP	NN	O	12	NMOD
12	infection	infection	I-NP	NN	O	9	PMOD
13	in	in	B-PP	IN	O	12	NMOD
14	children	child	B-NP	NNS	O	13	PMOD
15	]	]	O	)	O	0	ROOT
16	.	.	O	.	O	15	P

1	To	To	B-VP	TO	O	2	VMOD
2	study	study	I-VP	VB	O	0	ROOT
3	the	the	B-NP	DT	O	4	NMOD
4	value	value	I-NP	NN	O	2	OBJ
5	of	of	B-PP	IN	O	4	NMOD
6	multiple	multiple	B-NP	JJ	O	8	NMOD
7	Helicobacter	Helicobacter	I-NP	NN	O	8	NMOD
8	pylori	pylori	I-NP	NN	O	13	NMOD
9	(	(	O	(	O	11	DEP
10	H.pylori	H.pylori	B-NP	NN	O	11	DEP
11	)	)	O	)	O	8	NMOD
12	antibody	antibody	B-NP	NN	O	13	NMOD
13	detection	detection	I-NP	NN	O	5	PMOD
14	by	by	B-PP	IN	O	4	NMOD
15	protein	protein	B-NP	NN	O	16	NMOD
16	array	array	I-NP	NN	O	14	PMOD
17	in	in	B-PP	IN	O	4	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	diagnosis	diagnosis	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	H.pylori	H.pylori	B-NP	NN	O	22	NMOD
22	infection	infection	I-NP	NN	O	20	PMOD
23	in	in	B-PP	IN	O	22	NMOD
24	children	child	B-NP	NNS	O	23	PMOD
25	.	.	O	.	O	2	P

1	Biopsy	Biopsy	B-NP	NN	O	2	NMOD
2	specimens	specimen	I-NP	NNS	O	13	SUB
3	obtained	obtain	B-VP	VBN	O	2	NMOD
4	by	by	B-PP	IN	O	3	VMOD
5	gastroscopy	gastroscopy	B-NP	NN	O	4	PMOD
6	from	from	B-PP	IN	O	5	NMOD
7	120	120	B-NP	CD	O	8	NMOD
8	children	child	I-NP	NNS	O	6	PMOD
9	with	with	B-PP	IN	O	8	NMOD
10	digestive	digestive	B-NP	JJ	O	12	NMOD
11	system	system	I-NP	NN	O	12	NMOD
12	symptoms	symptom	I-NP	NNS	O	9	PMOD
13	were	be	B-VP	VBD	O	0	ROOT
14	detected	detect	I-VP	VBN	O	13	VC
15	by	by	B-PP	IN	O	14	VMOD
16	rapid	rapid	B-NP	JJ	O	18	NMOD
17	urease	urease	I-NP	NN	O	18	NMOD
18	test	test	I-NP	NN	O	25	NMOD
19	(	(	O	(	O	21	DEP
20	RUT	RUT	B-NP	NN	O	21	DEP
21	)	)	O	)	O	18	NMOD
22	and	and	O	CC	O	25	NMOD
23	modified	modify	B-VP	VBN	O	25	NMOD
24	Giemsa	Giemsa	B-NP	NNP	O	25	NMOD
25	staining	staining	I-NP	NN	O	15	PMOD
26	.	.	O	.	O	13	P

1	Positivity	Positivity	B-NP	NN	O	8	SUB
2	in	in	B-PP	IN	O	1	NMOD
3	both	both	O	CC	O	7	NMOD
4	RUT	RUT	B-NP	NN	O	7	NMOD
5	and	and	O	CC	O	7	NMOD
6	Giemsa	Giemsa	B-NP	NNP	O	7	NMOD
7	staining	staining	I-NP	NN	O	2	PMOD
8	was	be	B-VP	VBD	O	0	ROOT
9	the	the	B-NP	DT	O	12	NMOD
10	``	``	I-NP	``	O	12	NMOD
11	gold	gold	I-NP	NN	O	12	NMOD
12	criterion	criterion	I-NP	NN	O	8	PRD
13	''	''	O	''	O	12	NMOD
14	of	of	B-PP	IN	O	12	NMOD
15	H.pylori	H.pylori	B-NP	NNP	O	16	NMOD
16	infection	infection	I-NP	NN	O	14	PMOD
17	.	.	O	.	O	8	P

1	Serum	Serum	B-NP	NN	O	2	NMOD
2	samples	sample	I-NP	NNS	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	these	these	B-NP	DT	O	5	NMOD
5	patients	patient	I-NP	NNS	O	3	PMOD
6	were	be	B-VP	VBD	O	42	VMOD
7	obtained	obtain	I-VP	VBN	O	6	VC
8	and	and	O	CC	O	42	VMOD
9	the	the	B-NP	DT	O	10	NMOD
10	antibodies	antibody	I-NP	NNS	B-protein	42	SUB
11	against	against	B-PP	IN	O	10	NMOD
12	cytotoxin	cytotoxin	B-NP	NN	B-protein	16	NMOD
13	associated	associate	I-NP	VBN	O	12	AMOD
14	gene	gene	I-NP	NN	O	16	NMOD
15	A	A	I-NP	NN	O	16	NMOD
16	protein	protein	I-NP	NN	O	11	PMOD
17	(	(	O	(	O	19	DEP
18	CagA	CagA	B-NP	NN	B-protein	19	DEP
19	)	)	O	)	O	16	NMOD
20	,	,	O	,	O	10	P
21	vacuolating	vacuolate	B-VP	VBG	O	10	NMOD
22	toxin	toxin	B-NP	NN	O	23	NMOD
23	A	A	I-NP	NN	O	38	NMOD
24	(	(	O	(	O	26	DEP
25	VacA	VacA	B-NP	NN	B-protein	26	DEP
26	)	)	O	)	O	23	NMOD
27	,	,	O	,	O	38	P
28	urease	urease	B-NP	NN	O	38	NMOD
29	,	,	O	,	O	38	P
30	heat	heat	B-NP	NN	B-protein	32	NMOD
31	shock	shock	I-NP	NN	I-protein	32	NMOD
32	protein	protein	I-NP	NN	I-protein	38	NMOD
33	60	60	I-NP	CD	I-protein	32	NMOD
34	(	(	O	(	O	36	DEP
35	Hsp60	Hsp60	B-NP	NN	B-protein	36	DEP
36	)	)	O	)	O	32	NMOD
37	and	and	O	CC	O	38	NMOD
38	RdxA	RdxA	B-NP	NN	B-protein	21	OBJ
39	(	(	O	(	O	41	DEP
40	nitroreductase	nitroreductase	B-NP	NN	B-protein	41	DEP
41	)	)	O	)	O	38	NMOD
42	were	be	B-VP	VBD	O	0	ROOT
43	detected	detect	I-VP	VBN	O	42	VC
44	by	by	B-PP	IN	O	43	VMOD
45	protein	protein	B-NP	NN	O	47	NMOD
46	array	array	I-NP	NN	O	47	NMOD
47	technique	technique	I-NP	NN	O	44	PMOD
48	.	.	O	.	O	42	P

1	H.pylori	H.pylori	B-NP	NN	O	2	NMOD
2	infection	infection	I-NP	NN	O	3	SUB
3	was	be	B-VP	VBD	O	0	ROOT
4	identified	identify	I-VP	VBN	O	3	VC
5	according	accord	B-PP	VBG	O	4	VMOD
6	to	to	B-PP	TO	O	5	PMOD
7	the	the	B-NP	DT	O	10	NMOD
8	``	``	I-NP	``	O	10	NMOD
9	gold	gold	I-NP	NN	O	10	NMOD
10	criterion	criterion	I-NP	NN	O	6	PMOD
11	''	''	O	''	O	10	NMOD
12	in	in	B-PP	IN	O	10	NMOD
13	60	60	B-NP	CD	O	14	NMOD
14	children	child	I-NP	NNS	O	12	PMOD
15	.	.	O	.	O	3	P

1	Compared	Compare	B-PP	VBN	O	15	NMOD
2	with	with	B-PP	IN	O	1	VMOD
3	the	the	B-NP	DT	O	6	NMOD
4	``	``	I-NP	``	O	6	NMOD
5	gold	gold	I-NP	NN	O	6	NMOD
6	criterion	criterion	I-NP	NN	O	2	PMOD
7	''	''	O	''	O	6	NMOD
8	,	,	O	,	O	15	P
9	the	the	B-NP	DT	O	10	NMOD
10	goodness	goodness	I-NP	NN	O	15	NMOD
11	of	of	B-PP	IN	O	10	NMOD
12	fit	fit	B-NP	NN	O	11	PMOD
13	and	and	O	CC	O	15	NMOD
14	the	the	B-NP	DT	O	15	NMOD
15	coefficient	coefficient	I-NP	NN	O	31	SUB
16	of	of	B-PP	IN	O	15	NMOD
17	contingency	contingency	B-NP	NN	O	16	PMOD
18	in	in	B-PP	IN	O	15	NMOD
19	the	the	B-NP	DT	O	20	NMOD
20	diagnosis	diagnosis	I-NP	NN	O	18	PMOD
21	of	of	B-PP	IN	O	20	NMOD
22	H.pylori	H.pylori	B-NP	NN	O	23	NMOD
23	infection	infection	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	the	the	B-NP	DT	O	28	NMOD
26	following	follow	I-NP	VBG	O	28	NMOD
27	four	four	I-NP	CD	O	28	NMOD
28	groups	group	I-NP	NNS	O	30	NMOD
29	antibody	antibody	I-NP	NN	O	30	NMOD
30	detection	detection	I-NP	NN	O	24	PMOD
31	were	be	B-VP	VBD	O	0	ROOT
32	all	all	B-ADJP	RB	O	31	PRD
33	statistically	statistically	I-ADJP	RB	O	32	AMOD
34	significant	significant	I-ADJP	JJ	O	32	AMOD
35	(	(	O	(	O	39	DEP
36	P	P	B-NP	NN	O	38	SUB
37	<	<	O	SYM	O	38	VMOD
38	0.001	0.001	B-NP	CD	O	39	DEP
39	)	)	O	)	O	32	AMOD
40	:	:	O	:	O	31	P
41	anti-Ure	anti-Ure	B-NP	JJ	B-protein	42	NMOD
42	antibody	antibody	I-NP	NN	I-protein	46	NMOD
43	alone	alone	B-ADVP	RB	O	42	NMOD
44	,	,	O	,	O	46	P
45	anti-Ure	anti-Ure	B-NP	JJ	B-protein	46	NMOD
46	antibody	antibody	I-NP	NN	I-protein	31	VMOD
47	combined	combine	B-VP	VBN	O	46	NMOD
48	with	with	B-PP	IN	O	47	VMOD
49	anti-CagA	anti-CagA	B-NP	JJ	B-protein	50	NMOD
50	antibody	antibody	I-NP	NN	I-protein	53	NMOD
51	,	,	O	,	O	53	P
52	anti-Ure	anti-Ure	B-NP	JJ	B-protein	53	NMOD
53	antibody	antibody	I-NP	NN	I-protein	48	PMOD
54	combined	combine	B-VP	VBN	O	53	NMOD
55	with	with	B-PP	IN	O	54	VMOD
56	anti-VacA	anti-VacA	B-NP	JJ	B-protein	57	NMOD
57	antibody	antibody	I-NP	NN	I-protein	60	NMOD
58	and	and	O	CC	O	60	NMOD
59	anti-Ure	anti-Ure	B-NP	JJ	B-protein	60	NMOD
60	antibody	antibody	I-NP	NN	I-protein	55	PMOD
61	combined	combine	B-VP	VBN	O	60	NMOD
62	with	with	B-PP	IN	O	61	VMOD
63	anti-CagA	anti-CagA	B-NP	JJ	O	66	NMOD
64	and	and	I-NP	CC	O	66	NMOD
65	anti-VacA	anti-VacA	I-NP	JJ	B-protein	66	NMOD
66	antibody	antibody	I-NP	NN	I-protein	62	PMOD
67	.	.	O	.	O	31	P

1	The	The	B-NP	DT	O	6	NMOD
2	sensitivity	sensitivity	I-NP	NN	O	6	NMOD
3	,	,	I-NP	,	O	6	P
4	specificity	specificity	I-NP	NN	O	6	NMOD
5	and	and	I-NP	CC	O	6	NMOD
6	accuracy	accuracy	I-NP	NN	O	23	SUB
7	of	of	B-PP	IN	O	6	NMOD
8	the	the	B-NP	DT	O	9	NMOD
9	detection	detection	I-NP	NN	O	7	PMOD
10	of	of	B-PP	IN	O	9	NMOD
11	anti-Ure	anti-Ure	B-NP	JJ	B-protein	12	NMOD
12	antibody	antibody	I-NP	NN	I-protein	10	PMOD
13	combined	combine	B-VP	VBN	O	12	NMOD
14	with	with	B-PP	IN	O	13	VMOD
15	anti-CagA	anti-CagA	B-NP	JJ	B-protein	16	NMOD
16	antibody	antibody	I-NP	NN	I-protein	14	PMOD
17	for	for	B-PP	IN	O	16	NMOD
18	the	the	B-NP	DT	O	19	NMOD
19	diagnosis	diagnosis	I-NP	NN	O	17	PMOD
20	of	of	B-PP	IN	O	19	NMOD
21	H.pylori	H.pylori	B-NP	NN	O	22	NMOD
22	infection	infection	I-NP	NN	O	20	PMOD
23	were	be	B-VP	VBD	O	0	ROOT
24	81.7	81.7	B-NP	CD	O	25	NMOD
25	%	%	I-NP	NN	O	31	NMOD
26	,	,	O	,	O	31	P
27	91.7	91.7	B-NP	CD	O	28	NMOD
28	%	%	I-NP	NN	O	31	NMOD
29	and	and	O	CC	O	31	NMOD
30	86.7	86.7	B-NP	CD	O	31	NMOD
31	%	%	I-NP	NN	O	23	PRD
32	,	,	O	,	O	31	P
33	respectively	respectively	B-ADVP	RB	O	31	NMOD
34	.	.	O	.	O	23	P

1	The	The	B-NP	DT	O	3	NMOD
2	antibody	antibody	I-NP	NN	O	3	NMOD
3	detection	detection	I-NP	NN	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	a	a	B-NP	DT	O	9	NMOD
6	high	high	I-NP	JJ	O	9	NMOD
7	positive	positive	I-NP	JJ	O	9	NMOD
8	predictive	predictive	I-NP	JJ	O	9	NMOD
9	value	value	I-NP	NN	O	19	NMOD
10	(	(	O	(	O	13	DEP
11	90.7	90.7	B-NP	CD	O	12	NMOD
12	%	%	I-NP	NN	O	13	DEP
13	)	)	O	)	O	9	NMOD
14	and	and	O	CC	O	19	NMOD
15	a	a	B-NP	DT	O	19	NMOD
16	high	high	I-NP	JJ	O	19	NMOD
17	negative	negative	I-NP	JJ	O	19	NMOD
18	predictive	predictive	I-NP	JJ	O	19	NMOD
19	value	value	I-NP	NN	O	4	OBJ
20	(	(	O	(	O	23	DEP
21	83.3	83.3	B-NP	CD	O	22	NMOD
22	%	%	I-NP	NN	O	23	DEP
23	)	)	O	)	O	19	NMOD
24	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	antibody	antibody	I-NP	NN	O	3	NMOD
3	detection	detection	I-NP	NN	O	10	NMOD
4	by	by	B-PP	IN	O	3	NMOD
5	protein	protein	B-NP	NN	O	6	NMOD
6	array	array	I-NP	NN	O	4	PMOD
7	,	,	O	,	O	10	P
8	especially	especially	B-ADVP	RB	O	10	NMOD
9	the	the	B-NP	DT	O	10	NMOD
10	detection	detection	I-NP	NN	O	19	SUB
11	of	of	B-PP	IN	O	10	NMOD
12	anti-Ure	anti-Ure	B-NP	JJ	B-protein	13	NMOD
13	antibody	antibody	I-NP	NN	I-protein	11	PMOD
14	combined	combine	B-VP	VBN	O	13	NMOD
15	with	with	B-PP	IN	O	14	VMOD
16	anti-CagA	anti-CagA	B-NP	JJ	B-protein	17	NMOD
17	antibody	antibody	I-NP	NN	I-protein	15	PMOD
18	,	,	O	,	O	10	P
19	is	be	B-VP	VBZ	O	0	ROOT
20	valuable	valuable	B-ADJP	JJ	O	19	PRD
21	in	in	B-PP	IN	O	19	VMOD
22	the	the	B-NP	DT	O	23	NMOD
23	diagnosis	diagnosis	I-NP	NN	O	21	PMOD
24	of	of	B-PP	IN	O	23	NMOD
25	H.pylori	H.pylori	B-NP	NN	O	26	NMOD
26	infection	infection	I-NP	NN	O	24	PMOD
27	.	.	O	.	O	19	P

